Revolution Medicines Ownership & Insider Activity

Revolution Medicines Inc

RVMDNASDAQ

Trade with Public

$204.97

5.112.56%

近くで: Sep 25, 5:00 PM EST

$207.01

2.041%

時間外: Sep 25, 6:35 PM EST

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Revolution Medicines Ownership & Insider Activity

Revolution Medicines (RVMD) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 1.8% of shares outstanding. Institutional investors hold 50.8%. Over the past 90 days, insiders made 14 sales worth $55.3M.

Shares Outstanding

214.336M

Shares Float

202.974M

Insider Shares Owned

3.901M

Insider % Owned

1.8%

Institutional Shares Held

108.979M

Institutional % Held

50.8%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$55.3M total

Net Activity

Net Selling

Net Value (90d)

-$55.3M

Revolution Medicines Insider Transactions (Last 6 Months)

すべてのインサイダー取引を見る →

Date	Insider	Title	Type	Shares	Price	Value
Sep 22, 2026	Elizabeth M Anderson	—	SELL	5.073K	$97.08	$2.0M
Sep 18, 2026	Anthony Mancini	SEE REMARKS	SELL	1.764K	$196.94	$347K
Sep 16, 2026	Alan B Sandler	CHIEF DEVELOPMENT OFFICER	SELL	341.000	$199.24	$68K
Sep 16, 2026	Anthony Mancini	SEE REMARKS	SELL	1.774K	$199.24	$353K
Sep 16, 2026	Stephen Michael Kelsey	SEE REMARKS	SELL	5.569K	$199.24	$1.1M
Sep 16, 2026	Margaret A Horn	CHIEF OPERATING OFFICER	SELL	4.967K	$199.24	$990K
Sep 16, 2026	Mark A Goldsmith	SEE REMARKS	SELL	13.988K	$199.24	$2.8M
Sep 16, 2026	Jeff Cislini	SVP & GENERAL COUNSEL	SELL	3.366K	$199.24	$671K
Sep 16, 2026	Jack Anders	CHIEF FINANCIAL OFFICER	SELL	4.053K	$199.24	$808K
Sep 11, 2026	Stephen Michael Kelsey	SEE REMARKS	SELL-OPTIONS	—	$122.04	$14.9M
Sep 10, 2026	Anthony Mancini	SEE REMARKS	SELL	6.085K	$118.89	$2.8M
Sep 8, 2026	Lorence H Kim	—	SELL	17.090K	$209.82	$3.6M
Aug 31, 2026	Lorence H Kim	—	SELL	56.000K	$203.24	$11.4M
Aug 21, 2026	Jeff Cislini	GENERAL COUNSEL	SELL	614.000	$114.62	$10.8M
Aug 21, 2026	Mark A Goldsmith	SEE REMARKS	SELL	6.000K	$106.96	$17.6M
Jun 29, 2026	Sushil Patel	—	SELL	2.625K	$112.76	$938K
Jun 24, 2026	Jack Anders	CHIEF FINANCIAL OFFICER	SELL-OPTIONS	—	$93.45	$3.0M
Jun 16, 2026	Anthony Mancini	SEE REMARKS	SELL	4.615K	$156.12	$720K
Jun 16, 2026	Mark A Goldsmith	SEE REMARKS	SELL	10.020K	$156.12	$1.6M
Jun 16, 2026	Jeff Cislini	GENERAL COUNSEL	SELL	2.157K	$156.12	$337K
Jun 16, 2026	Jack Anders	CHIEF FINANCIAL OFFICER	SELL	2.722K	$156.12	$425K
Jun 16, 2026	Stephen Michael Kelsey	SEE REMARKS	SELL	4.175K	$156.12	$652K
Jun 11, 2026	Margaret Horn	CHIEF OPERATING OFFICER	SELL-OPTIONS	—	$94.47	$1.1M
May 26, 2026	Anthony Mancini	SEE REMARKS	SELL-OPTIONS	—	$93.81	$376K
Apr 27, 2026	Anthony Mancini	SEE REMARKS	SELL-OPTIONS	—	$83.02	$308K
Apr 15, 2026	Mark A Goldsmith	SEE REMARKS	SELL-OPTIONS	—	$77.35	$17.5M

More with Benzinga EdgeGet Access

Revolution Medicines Inc

Revolution Medicines Ownership & Insider Activity

Revolution Medicines Insider Transactions (Last 6 Months)

People Also Watch

ニュース

パートナーシップ

ベンジンガ・グローバル

People Also Watch